Literature DB >> 1975391

Deoxyspergualin for liver graft rejection.

C G Groth, S Ohlman, B G Ericzon, L Barkholt, F P Reinholt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1975391     DOI： 10.1016/0140-6736(90)93419-p

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  The changing face of liver transplantation.

Authors:  C Shorrock; J Neuberger
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

2.  Phase II study of deoxyspergualin in metastatic breast cancer.

Authors:  K Dhingra; V Valero; L Gutierrez; R Theriault; D Booser; F Holmes; A Buzdar; G Fraschini; G Hortobagyi
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Myeloprotective activity of deoxyspergualin: influence on splenic colony-forming cell injury and antitumor activity of mitomycin C in mice.

Authors:  K Nemoto; Y Sugawara; M Ogino; T Mae; F Abe; T Takeuchi
Journal:  Jpn J Cancer Res       Date:  1992-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.